1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Telotristat ethyl
Trade Name:
Xermelo
Manufacturer/Distributor:
Ipsen Biopharmaceuticals
Classification:
Tryptophan hydroxylase inhibitor
ATC Class:
A16AX15 - telotristat
Status:
active
Notice of Compliance (yyyy/mm/dd):
2018/10/10
Date Marketed in Canada (yyyy/mm/dd):
2018/10/12
Presentation:
Tablet: 250 mg. DIN: 02481553.
Comments:
For the treatment of refractory carcinoid syndrome diarrhea, in combination with somatostatin analogue (SSA) therapy, in patients inadequately controlled by SSA therapy alone.
Back to:
Drug Product Listings 
